Coinfection with Coxiella burnetii in infectious endocarditis  by Rovery, C. et al.
10.1111/j.1469-0691.2008.02221.x
Coinfection with Coxiella burnetii in infectious endocarditis
C. Rovery1, B. Granel2, J.-P. Casalta1, H. Lepidi1, G. Habib3 and D. Raoult1
1Unite´ des Rickettsies, CNRS-UMR6020, IFR48, Faculte´ de Me´decine, 2Service de Me´decine Interne,
Hoˆpital Nord and 3Service de Cardiologie, Hoˆpital de la Timone, Marseille, France
Currently, most cases of Q fever endocarditis are
diagnosed serologically, when levels of anti-phase
I antibodies are ‡1:800 [1]. In Marseille, France,
we proposed a systematic serological testing for
all pathogens that could cause negative blood
culture IE for all patients suspected to have IE. We
demonstrated that this approach is useful in
establishing the aetiological diagnosis of IE [2].
Thanks to this systematic serological testing, we
could diagnose four patients with IE due to a
typical microorganism and high antibody titres to
C. burnetii.
In a retrospective study, we enrolled patients,
hospitalised in Marseille, between April 1994 and
January 2007, with C. burnetti phase I IgG ‡1:800
and IE caused by another microorganism. The
modiﬁed Duke criteria were used to deﬁne cases
of endocarditis [3]. Each patient underwent test-
ing that was guided by a diagnostic kit as
described previously [2]. Titres of IgG, IgM and
IgA antibodies in serum samples were deter-
mined by the indirect immunoﬂuorescence assay
[2]. Valvular surgical samples or heparinised
blood samples were inoculated onto human
embryonic lung ﬁbroblasts grown on a coverslip
in a shell vial. After a 7-day incubation period at
37C, cultivated bacteria were detected by a direct
immunoﬂuorescence assay incorporating rabbit
monoclonal antibodies to C. burnetii. A DNA
extract was prepared from the valvular surgical
samples with the QIAmp tissue kit (Qiagen,
Hilden, Germany) and the QIAamp Blood Kit
(Qiagen) for blood samples according to the
manufacturer’s instructions. Bacterial DNA was
detected by PCR ampliﬁcation with universal
primers and sequencing of the ampliﬁed frag-
ment, as previously described [4]. For C. burnetii,
the PCR was performed using a LightCycler
apparatus (Roche), using two different target
genes: the IS1111 repeated intervening sequence
and the IS30a intervening sequence. Valvular
surgical samples, when available, were embedded
in parafﬁn, and sections were stained with hema-
toxylin-eosin-safran for histology. For detection of
C. burnetii in tissues, immunochemistry was done
on deparafﬁnised sections by use of an anti-C.
burnetii rabbit polyclonal antibody, as previously
described [5].
Four patients (6.5& of patients with IE tested)
had IE according to Duke’s criteria due to com-
mon endocarditis pathogens (Streptococcus gallo-
lyticus for patients 1 and 2, Streptococcus mitis for
patient 3, and Enterococcus faecalis for patient 4)
and anti-phase I C. burnetii antibodies ‡1:800.
Characteristics of the patients and microbiological
results are presented in Table 1. Only patient 1
had a past history of previous fever and asthenia
suggestive of Q fever. All these patients under-
went valvular surgery in the course of the disease.
The valvular sample of patient 1 was positive for
C. burnetii for the two targeted genes. Patient 3
had Q fever serology very suggestive of chronic
infection with high titres of IgG1 1:102 400 and
IgA1 1:12 800. Patients 2 and 4 had serology IgG1
of 1:800. For these two patients there was no other
evidence of chronic Q fever. All the patients were
treated for bacterial IE according to local guide-
lines and for Q fever endocarditis. All the patients
improved and remain healthy at present.
We report here four patients with IE due to
typical microorganisms and Q fever serology with
IgG1 ‡800. We could recover C. burnetii DNA in
valvular samples in patient 1. Patient 3 had very
high titres (1:102 400). We concluded that these
two patients surely had an ongoing chronic Q
fever. The two other patients with IgG1 1:800 had
no evidence of ongoing illness. Patient 1 and
patient 3 were included in a prospective study
evaluating the contribution of systematic serolog-
ical testing in the diagnosis of IE [2]. As witnessed
in these four cases, the diagnosis of Q fever may
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be delayed by many months because of the lack of
speciﬁc signs and symptoms. Only patient 1 had a
history of previous fever and asthenia 3 months
before that could be due to Q fever. Fever may be
absent in more than 18% of cases, and vague
constitutional symptoms, congestive heart failure
or valvular dysfunction may predominate. Be-
cause Q fever is associated with substantial
morbidity and mortality, it is necessary to opti-
mise the diagnosis of Q fever in patients with
encocarditis. We recommend testing for Q fever
endocarditis in any negative blood culture endo-
carditis, isolated inﬂammatory syndrome with
native-prosthetic valve, unexplained inﬂamma-
tory aspect of valve, or unexplained valve dys-
function. In conclusion, we identiﬁed in four
patients (6.5 & of patients with IE tested),
evidence of current or past infection by C. burnetii.
The 1 ⁄ 800 cut-off for C. burnetii is necessary for
sensitivity as shown by patient 1 but may not be
100% speciﬁc of Q fever IE.
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